相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study
Hamidreza Mani et al.
CLINICAL ENDOCRINOLOGY (2013)
High sensitivity C-reactive protein and its relationship with impaired glucose regulation in lean patients with polycystic ovary syndrome
Ji Won Kim et al.
GYNECOLOGICAL ENDOCRINOLOGY (2012)
Polycystic ovary syndrome: infertility, cardiovascular, metabolic and obstetrical risks, laboratory and clinical outcomes-The PICOLO Study
M. Aziz et al.
GYNECOLOGICAL ENDOCRINOLOGY (2012)
Consensus on women's health aspects of polycystic ovary syndrome (PCOS)
B. C. J. M. Fauser et al.
HUMAN REPRODUCTION (2012)
Coagulation and Fibrinolytic Disturbances in Women with Polycystic Ovary Syndrome
Louise Manneras-Holm et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Hemostatic Abnormalities and Relationships to Metabolic and Hormonal Status in Polycystic Ovarian Syndrome
Genia Burchall et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2011)
Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1
Mirjam E. Meltzer et al.
BLOOD (2010)
The insulin-resistant phenotype of polycystic ovary syndrome
Pernille Fog Svendsen et al.
FERTILITY AND STERILITY (2010)
Not all women diagnosed with PCOS share the same cardiovascular risk profiles
Vuk P. Jovanovic et al.
FERTILITY AND STERILITY (2010)
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
Stephen Kaptoge et al.
LANCET (2010)
Clinical significance of inflammatory markers in polycystic ovary syndrome: Their relationship to insulin resistance and Body Mass Index
Nervana Samy et al.
DISEASE MARKERS (2009)
Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome
Flavia Tosi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Polycystic Ovarian Syndrome and the Risk of Cardiovascular Disease and Thrombosis
Winifred Mak et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2009)
Von Willebrand Factor, Type 2 Diabetes Mellitus, and Risk of Cardiovascular Disease The Framingham Offspring Study
David S. Frankel et al.
CIRCULATION (2008)
Soluble CD36 and Risk Markers of Insulin Resistance and Atherosclerosis Are Elevated in Polycystic Ovary Syndrome and Significantly Reduced During Pioglitazone Treatment
Dorte Glintborg et al.
DIABETES CARE (2008)
Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance
Enrico Carmina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
PAI-1 antagonists: Predictable indications and unconventional applications
Douglas E. Vaughan et al.
CURRENT DRUG TARGETS (2007)
Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome
F Carmassi et al.
THROMBOSIS RESEARCH (2005)
The polycystic ovary syndrome per se is not associated with increased chronic inflammation
M Möhlig et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome
E Carmina et al.
FERTILITY AND STERILITY (2004)
The plasminogen activator system in young and lean women with polycystic ovary syndrome
I Tarkun et al.
ENDOCRINE JOURNAL (2004)
Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association
TA Pearson et al.
CIRCULATION (2003)
Long-term health consequences of PCOS
RA Wild
HUMAN REPRODUCTION UPDATE (2002)
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
